Neuromuscular blocking agent (NMBA)

Neuromuscular blocking agents (NMBAs) are a pharmacologic class, not a single molecular entity. They are drugs that block transmission of nerve impulses at the neuromuscular junction, thereby causing paralysis of skeletal muscles[1][5][6]. NMBAs are categorized as depolarizing (e.g., succinylcholine, which acts as an acetylcholine agonist causing persistent depolarization of muscle membrane until desensitization and paralysis) or nondepolarizing (e.g., rocuronium, vecuronium, pancuronium, atracurium, cisatracurium, which are competitive antagonists at the postsynaptic nicotinic acetylcholine receptor)[1][3][7]. They do not act on the central or autonomic nervous system, and do not provide sedation or analgesia, only muscle relaxation[5]. Clinical use is almost exclusively as adjuncts during anesthesia, intubation, or mechanical ventilation. NMBAs have significant safety risks, including the requirement for artificial ventilation due to respiratory muscle paralysis[6][8]. Key point: “Neuromuscular blocking agents” is a drug class, not a specific therapeutic target or molecule. The molecular targets of NMBAs are the postsynaptic nicotinic acetylcholine receptors (nAChRs) at the skeletal muscle neuromuscular junction. For structured information on a true target, the correct entity would be “Nicotinic acetylcholine receptor (muscle type)” or a specific subunit thereof. is_incorrect: true — because the entry is for a drug class, not a target molecule or receptor.

Other names

Neuromuscular-blocking drugneuromuscular paralyticmuscle relaxant (context-specific)curarizing agent (for the nondepolarizing class)

Depolarizing: Agonism at postsynaptic nicotinic acetylcholine receptors at the neuromuscular junction, causing sustained depolarization and muscle paralysis (e.g., succinylcholine) Nondepolarizing: Competitive antagonism of postsynaptic nicotinic acetylcholine receptors, inhibiting acetylcholine binding and thus preventing muscle contraction (e.g., rocuronium, vecuronium)[1][2][3][5]